Abstract
It has been reported that hyperprolactinemia may be associated with increased temporal lobe activity. Coexisting hyperprolactinemia (97.5 ± 3.2 ng/ml) related to a pituitary tumefaction (8 mm) and Temporal Lobe Epilepsy (TLE), were observed in a 37-year-old woman. Carbamazepin (CBZ) therapy induced a marked improvement in TLE symptoms and EEG recordings, but did not influence hyperprolactinemia and related symptoms. Long-lasting (27 months) normoprolactinemia (19.4 ± 0.6 ng/ml) and TLE relief were achieved on a dopamine (DA) agonist medication, e.g. pergolide mesylate, 25–50 μg/day given over 8 months, and persisted as long as 27 months after drug withdrawal. Posttreatment CT scans showed progressive shrinkage of the pituitary tumor (2 mm) associated with an empty-sella. It is proposed that, whenever TLE and hyperprolactinemia coexist, therapy with a DA agonist such as pergolide mesylate, resulting in normoprolactinemia, may be beneficial in TLE control.
Similar content being viewed by others
References
Herzog A.G., Seibel M.M., Schomer D.L., Vaitukaitis J.L., Geschwind N. Reproductive endocrine disorders in women with partial seizures of temporal lobe origin. Arch Neurol. 43: 34, 1986.
Herzog A.G., Seibel M.M., Schomer D.L., Vaitukaitis J.L., Geschwind N. Reproductive endocrine disorders in men with partial seizures of temporal lobe origin. Arch Neurol. 43: 34, 1986.
Spark R.F., Wills C.A., Royal H. Hypogonadis, hyperprolactinaemi, and temporal lobe epilepsy in hyposexual men. Lancet 1: 41, 1984.
Müller E.E., Cavagnini F., Martinez-Campos A., Maraschini C., Giovannini P., Novelli A., De Leo V. Dynamic testing of prolactin and growth hormone secretion in patients with neuroendocrine disorders. Acta Endocrinol. (Copenh) 107: 15, 1984.
Grossman A., Besser G.M. Prolactinomas. Br. Med. J. 290: 18, 1985.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gattereau, A., Vézina, J., Rousseau, S. et al. Hyperprolactinemia and temporal lobe epilepsy in a woman: concomitant and persistent prolactin suppression and temporal lobe epilepsy relief. J Endocrinol Invest 13, 247–249 (1990). https://doi.org/10.1007/BF03349551
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03349551